Xoterna Breezhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Xoterna Breezhaler, covering 2025-07-25 to 2025-07-25. Get the full timeline:
Most recent: EMA Authorised: Xoterna Breezhaler (indacaterol;glycopyrronium bromide) — Novartis Europharm Limited